Market Trends of Facial Care Industry
The Dermal Fillers Segment is Expected to Witness Significant Growth Over the Forecast Period
Dermal Filler is a gel-like substance, such as hyaluronic acid (HA), that is injected under the skin to improve the appearance of the skin, make skin plump up, smoothen the fine lines, etc. Dermal filler has a wide application in facial care for wrinkle reductions, improvement of skin appearance, lip augmentation, and others. The procedure of dermal fillers has been on the rise globally, which is expected to boost the growth of the segment. For instance, as per the data published by the ISAPS survey in 2021, over 5.3 million procedures of hyaluronic acid alone were performed in 2021 globally, which showed an increase of 30.3% as compared to the previous year.
Furthermore, several research studies have shown the high efficacy, safety, and wide applications of dermal fillers for facial care, which depicts the vast potential of dermal fillers for more demand in the future. For instance, a study published in the Journal of Cosmetic Dermatology in May 2022 stated that hyaluronic acid fillers are effective for the purpose of dermal fillers for improving facial appearance. The study mentioned that the HA dermal filler showed safety and efficacy to be used in the Chinese population for lip augmentation. Further, a multicenter study published in the Dermatologic Surgery in July 2021 demonstrated the long-term efficacy and safety of the polycaprolactone-dermal filler (PCL-filler) for the management of moderate/severe nasolabial folds having the WSRS (wrinkle severity rating scale) of 3 to 4, for a month. Thus, the high efficacy, safety, and wide applications of dermal fillers are expected to create more growth opportunities for the segment.
Also, the key developments by the market players in dermal fillers are also boosting the growth of the segment. For instance, in February 2022, Allergan Aesthetics, an AbbVie company, received FDA approval for its dermal filler JUVÉDERM VOLBELLA XC, which is intended for improvisation of the infraorbital hollows or undereye hollows, in adults over the age of 21 years. The launch of the dermal filler would enable the company to expand its treatment portfolio to address the unmet needs of the patient.
Therefore, the dermal fillers segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including its efficiency, safety, and recent product launches.
North America is Expected to Witness Significant Growth Over the Forecast Period
North America is expected to witness significant growth during the forecast period, with the high volume of aesthetic/cosmetic procedures, advanced healthcare and research infrastructure, and the presence of leading players.
The region has a high volume of cosmetic or aesthetic procedures, which also include facial care procedures. For instance, as per the data published by the International Society of Aesthetic Plastic Surgery (ISAPS) Survey in 2021, the United States performs one of the highest numbers of surgical and non-surgical procedures related to aesthetics. The survey stated that over 5,355,604 non-surgical procedures and 1,992,296 surgical procedures were performed in 2021 in the United States. The same source also stated that over 542,605 facial rejuvenation procedures were performed in the United States in 2021. Further, the survey also stated that over 33,750 and 39,305 procedures of lip enhancement/ perioral procedures were performed in the United States and Mexico, respectively, in 2021.
Furthermore, the presence of leading players and their key developments in the region are also expected to boost the growth of the market in North America. For instance, in February 2021, Galderma received USFDA approval for its chin filler, Restylane Defyne. The dermal filler is intended for the correction and augmentation of mild to moderate chin retrusion for adults over the age of 21 years.
Therefore, owing to the aforementioned factors, including the high volume of cosmetic procedures, high disposable income, and recent developments by the key players, the growth of the studied market is anticipated in the North America region.
